When we separately analyzed TNBC and ER+ / HER2+ cancer cells, we found no major differences in levels of CLEC10A expression (Fig. S6), but significant differences in the number of CLEC10A expressing cells (Fig. 6). This evidence concerns the gene ESR1 and cancer.